Lypova, N.; Lanceta, L.; Gipson, A.; Vega, S.; Garza-Morales, R.; McMasters, K.M.; Chesney, J.; Gomez-Gutierrez, J.G.; Imbert-Fernandez, Y.
Targeting Palbociclib-Resistant Estrogen Receptor-Positive Breast Cancer Cells via Oncolytic Virotherapy. Cancers 2019, 11, 684.
https://doi.org/10.3390/cancers11050684
AMA Style
Lypova N, Lanceta L, Gipson A, Vega S, Garza-Morales R, McMasters KM, Chesney J, Gomez-Gutierrez JG, Imbert-Fernandez Y.
Targeting Palbociclib-Resistant Estrogen Receptor-Positive Breast Cancer Cells via Oncolytic Virotherapy. Cancers. 2019; 11(5):684.
https://doi.org/10.3390/cancers11050684
Chicago/Turabian Style
Lypova, Nadiia, Lilibeth Lanceta, Alana Gipson, Stephanie Vega, Rodolfo Garza-Morales, Kelly M. McMasters, Jason Chesney, Jorge G. Gomez-Gutierrez, and Yoannis Imbert-Fernandez.
2019. "Targeting Palbociclib-Resistant Estrogen Receptor-Positive Breast Cancer Cells via Oncolytic Virotherapy" Cancers 11, no. 5: 684.
https://doi.org/10.3390/cancers11050684
APA Style
Lypova, N., Lanceta, L., Gipson, A., Vega, S., Garza-Morales, R., McMasters, K. M., Chesney, J., Gomez-Gutierrez, J. G., & Imbert-Fernandez, Y.
(2019). Targeting Palbociclib-Resistant Estrogen Receptor-Positive Breast Cancer Cells via Oncolytic Virotherapy. Cancers, 11(5), 684.
https://doi.org/10.3390/cancers11050684